Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans
Yongkang Yang,Jiaming Wu,Xia Wang,Jianyu Yao,Kim Shijian Lao,Yumei Qiao,Ying Xu,Yue Hu,Yanhong Feng,Yanchao Cui,Shuai Shi,Jing Zhang,Man Liang,Yong Pan,Kang Xie,Kaixuan Yan,Qin Li,Dewei Ye,Yao Wang
DOI: https://doi.org/10.1016/j.fertnstert.2021.05.098
IF: 6.7
2021-10-01
Fertility and Sterility
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To investigate whether serum levels of fibroblast growth factor 21 (FGF21) and fatty acid-binding protein-4 (FABP4) are associated with missed abortion (MA) in humans.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Design</h3><p>Cross-sectional study.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Setting</h3><p>University-affiliated hospital.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Patient(s)</h3><p>Patients with MA at 8–12 weeks of gestation.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Intervention(s)</h3><p>None.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Main Outcome Measures(s)</h3><p>Serum levels of FGF21 and FABP4 were tested by enzyme-linked immunosorbent assay. Placental samples were collected during dilation and curettage surgery, and the expression of <em>FGF21</em> and its related genes were measured using quantitative polymerase chain reaction.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Result(s)</h3><p>In the discovery cohort, 78 patients with MA and 79 healthy pregnant women matched for maternal age and body mass index were nested from a prospective cohort. Circulating levels of FGF21 and FABP4 were significantly and independently elevated in patients with MA relative to the levels in the healthy controls. A single measurement of FGF21 serum level effectively discriminated MA with an area under the receiver operating characteristics curve of 0.80 (95% confidence interval: 0.73–0.87). Importantly, in our external validation cohort that comprised subjects with MA (n = 34) or induced abortion (n = 27), the FGF21 serum levels achieved an area under the receiver operating characteristics curve of 0.85 (95% confidence interval: 0.75–0.96) when identifying those with MA. Nevertheless, expression of FGF21 in the placenta was not associated with its serum concentration. Placental tissues from patients with MA exhibited impaired FGF21 signaling.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion(s)</h3><p>Our results suggested that serum levels of FGF21 and FABP4 were associated with MA. Circulating FGF21 may serve as a potential biomarker for the recognition of MA.</p>
obstetrics & gynecology,reproductive biology